tionship between the phospholipase A2 inhibitor dexamethasone and both the reduced bacterial clearance and increased larval mortality. The dexamethasone effects on larval survival were reversed by treatment with arachidonic acid. Maleic acid, a nonspecific antioxidant, did not interfere with the insects' ability to remove bacterial cells from hemolymph. The larvae were shown to contain all of the C20 polyunsaturated fatty acids necessary for eicosanoid biosynthesis and to be capable of converting radioactive arachidonic acid into several primary prostaglandins. These results strongly suggest that eicosanoids mediate transduction of bacterial infection signals into the complex of cellular and humoral responses that comprise invertebrate immunity.
Invertebrate immunity is an amalgam of several distinct systems, both cellular and humoral, that operate in a more or less coordinated way to provide protection from invading pathogens (1) . Cellular responses include phagocytosis, encapsulation, and various cytotoxic reactions such as release of lysozyme (1, 2) and the prophenoloxidase activating system (3) . These hemocyte-mediated responses are complemented by antibacterial activity, such as lectins, which occur constitutively in invertebrate hemolymph (4) . In addition to normally occurring factors, several antibacterial peptides are induced by bacterial infections [namely, the cecropins (4 kDa), attacins (21 to 23 kDa), diptericins (8 kDa) , and insect defensins (4 kDa)] (3, 5) .
An important area of invertebrate immunity that has not been critically addressed concerns how the early responses to infection are mediated-that is, what is the sequence of biochemical events operative between microbial invasion and the appearance of defense mechanisms? To date, only two early steps in the immune response have been investigated. In one, immune-specific RNA was shown to be synthesized 2-4 hr after bacterial infection of the moths Hyalophora cecropia and Galleria mellonella (3) . In the other, inducible lectins were synthesized in the flesh fly Sarcophaga peregrina almost immediately after their immune system was challenged (6) . However, these genespecific events follow from earlier steps in transduction of bacterial invasion signals into physiological defense responses.
Since many aspects of immunological defense in mammals are mediated by eicosanoid metabolites of arachidonic acid (7), we hypothesized that biosynthesis of eicosanoids is also an essential early step in mediation of the immune response in invertebrates. We tested this hypothesis by using an insect, the tobacco hornworm Manduca sexta. We report here that selective pharmaceutical inhibitors of eicosanoid biosynthesis compromise the hornworm's immune response to bacterial infection. Furthermore, hornworms so compromised died earlier in the course of infection than did control animals. These findings indicate that eicosanoid biosynthesis is a crucial early step in invertebrate immunity.
MATERIALS AND METHODS
Organisms. Larval tobacco hornworms were reared under standard culture conditions (8) , at 280C under a 16-hr light/ 8-hr dark photoperiod. Experiments used early fifth (last prepupal) instar prewandering larvae. The bacterium Serratia marcescens used in this study is a red-pigmented strain obtained from the culture collection, School of Biological Sciences at the University of Nebraska-Lincoln. Bacteria were grown in 50 ml of standard methods broth (Difco) on a waterbath shaker at 300C and 120 rpm. The cells were used in midlogarithmic or stationary phase at a titer of 2.5-7.0 x 107 colony-forming units (cfu) per ml.
Bacterial Recovery: Influence of Inhibitors. Test larvae were injected with either the phospholipase A2 (PLA2) inhibitor dexamethasone [(11/3,16a)-9-fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione], the cyclooxygenase inhibitor indomethacin [1-(p-chlorobenzoyl)-5-methoxy-2-methyl-3-indolyl-acetic acid], the 5-and 12-lipoxygenase inhibitor esculetin (6,7- Fig. 1 shows that the median bacterial recovery from ethanol-treated control larvae was below the limits of detectability for the first hour PI (<103 cfu per ml of hemolymph; n = 27 for all time points), indicating that the larvae are able to remove injected bacteria from their hemolymph. In contrast, the dexamethasonetreated larvae yielded a median value of 1. Bacteria were recovered from significantly more larvae treated with eicosanoid biosynthesis inhibitors than from control larvae. Red-pigmented S. marcescens bacterial colonies were seen on 87% of the agar plates from dexamethasone-treated larvae, whereas only 21% of the plates from control larvae had visible colonies (W = 361.5, P = 0.0007). Fig. 2 shows that larvae treated with compounds that block only one of the two main PUFA oxygenation pathways 46 .3% of the ethanol-treated control larvae were still alive. However (Fig. 4) The larval deaths could, of course, have been due to toxic effects of dexamethasone. We eliminated this possibility with a series of experiments by injecting unchallenged larvae with large doses (50 ,ug) of dexamethasone, ethanol (the dexamethasone vehicle), the cell-free bacterial culture broth, and arachidonic acid. In all cases the larvae did not die during the 24-hr experimental period and showed no observable behavioral effects. These findings indicate that reduced ability to clear bacteria from hemolymph is associated with their earlier death from pathogenic infections.
Arachidonic Acid Reversed the Dexamethasone Effects. As we have just seen, dexamethasone greatly reduced the proportion of larvae that survived S. marcescens infections (Fig.  4) . However, this dexamethasone effect was reversed by PUFA Composition. Analysis of fatty acid compositions of phospholipids purified from hemolymph showed that all three eicosanoid precursor PUFAs were present in M. sexta. These three components accounted for about 1% of total phospholipid fatty acids, comparable to results from many other terrestrial insect species (10); of these precursor PUFAs, 20:3 (n -6) made up 20%, 20:4 (n -6) made up 34%, and 20:5 (n -3) made up 46%. Retention times and mass spectra of these compounds were exactly congruent with authentic standards. Thus, all potential eicosanoid precursors were present in this insect in sufficient quantities to support eicosanoid biosynthesis.
Eicosanoid Biosynthesis from Arachidonic Acid. Larvae of M. sexta were able to convert radioactive arachidonic acid into eicosanoids. One minute after injection, 100-,ul hemolymph samples were withdrawn from each of seven larvae. In these samples, 5.3% of the injected radioactivity (mean = 2.9 x 105 dpm) was recovered. Most (95-97%) of the recovered radioactivity was arachidonic acid. Three fractions (expressed as the percentage of recovered radioactivity + 1 SD, n = 7) had chromatographic behavior identical to the prostaglandins F2, (0.1% + 0.01%), E2 (0.1% ± 0.02%), and D2 (0.5% ± 0.2%). A similar amount of radioactivity was also recovered in an otherwise uncharacterized fraction in the same Rf range reported for lipoxygenase metabolites in mammalian systems, presumably hydroxyeicosatetraenoic acids (12) .
DISCUSSION
In vertebrates and invertebrates, eicosanoids are formed from unesterified C20 PUFAs, which arise primarily by action of PLA2 on phospholipid components of membranes (13) . Once available, these PUFAs can be oxygenated by two main routes: the cyclooxygenase pathway, which leads to the biologically active prostaglandins, and the lipoxygenase pathway, which is a complex of pathways leading to hydroperoxyeicosatetraenoic acids, hydroxyeicosatetraenoic acids, leukotrienes, lipoxins, and hepoxilins (13, 14) . Products of both pathways are important in various aspects of mammalian host defense. For example, cyclooxygenase products have profound effects on macrophage locomotion, shape changes, and phagocytosis (15) , whereas lipoxygenase products mediate chemotaxis, chemokinesis, and adherence responses of neutrophils (7).
The results presented in this paper strongly support our hypothesis that eicosanoids also mediate invertebrate immune responses. This view is summarized in the following arguments. First, inhibition of eicosanoid formation with specific inhibitors of PLA2, cyclooxygenase, and lipoxygenase significantly reduced the ability of larvae to clear pathogenic bacteria from their hemolymph. Second, the reduced capability to clear bacteria was associated with increased mortality caused by these bacteria. Third, for dexamethasone, both the increased bacterial recovery and decreased larval survival were expressed in a dosedependent manner. Finally, the dexamethasone effects were reversed by treatment with arachidonic acid.
A major difficulty with using pharmaceutical inhibitors to probe biochemical pathways is the possibility of nonspecific or nonphysiological effects. The inhibitors used here are known to be very specific in mammals; less is known about their specificity in invertebrate systems. We feel the extrapolation to M. sexta is justified by four examples where these compounds have been shown to have similar pharmacological action in invertebrates and mammals. First, acetylsalicylic acid (aspirin) inhibits prostaglandin biosynthesis in microsomal preparations from cockroach fat body (16) , in in vitro preparations from house flies (17) , and in reproductive tissues of the cricket Teleogryllus commodus (18) . Second, indomethacin inhibits prostaglandin-mediated oviposition behavior in silk moths (19) . Third, the PLA2 inhibitor dexamethasone mimics the effects of essential arachidonic acid deficiency in the mosquito Culex pipiens (20) . Fourth, esculetin inhibits eicosanoid-mediated host penetration behavior of the blood fluke Schistosoma mansoni (21) (23) . Capillary column gas chromatography and mass spectrometric analysis confirmed the presence of all three known eicosanoid precursor PUFAs, 20:3 (n -6), 20:4 (n -6), and 20:5 (n -3), in phospholipids from hemolymph of M. sexta. We also observed biosynthesis of eicosanoids from radioactive precursor in M. sexta hemolymph. This evidence shows that M. sexta is competent to biosynthesize eicosanoids from arachidonic acid. It is expected that a wide range of eicosanoid species will prove to be components of a complex regulatory system that initiates and terminates many elements of the immunological response in invertebrates, as seen in mammals (7) .
Although we do not yet know the precise functions eicosanoids play in insect immunity, the timing of their action provides some insight. Our time course experiments show that the dexamethasone effect on clearing S. marcescens from hemolymph can be seen as early as 15 min PI. Rapid clearance of another insect pathogenic bacterium, Pseudomonas aeruginosa P11-1, from the hemolymph of M. sexta larvae has been described by Dunn and colleagues. This clearance was attributed to nodule formation at or near the injection site during the first 2 hr PI (24), followed by phagocytosis in the next 6 hr (25) . They correlated these observations with hemocyte population dynamics during the first hour PI (26, 27). We suggest that eicosanoid metabolism mediates some/all of these early defense responses.
